134 related articles for article (PubMed ID: 27626069)
41. Treatment of acute promyelocytic leukaemia.
Fenaux P; Chomienne C; Degos L
Best Pract Res Clin Haematol; 2001 Mar; 14(1):153-74. PubMed ID: 11355929
[TBL] [Abstract][Full Text] [Related]
42. Combination therapy with arsenic trioxide, all-trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia.
Aribi A; Kantarjian HM; Estey EH; Koller CA; Thomas DA; Kornblau SM; Faderl SH; Laddie NM; Garcia-Manero G; Cortes JE
Cancer; 2007 Apr; 109(7):1355-9. PubMed ID: 17326049
[TBL] [Abstract][Full Text] [Related]
43. Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing.
Masetti R; Castelli I; Astolfi A; Bertuccio SN; Indio V; Togni M; Belotti T; Serravalle S; Tarantino G; Zecca M; Pigazzi M; Basso G; Pession A; Locatelli F
Oncotarget; 2016 Aug; 7(35):56746-56757. PubMed ID: 27462774
[TBL] [Abstract][Full Text] [Related]
44. Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide.
Shen Y; Fu YK; Zhu YM; Lou YJ; Gu ZH; Shi JY; Chen B; Chen C; Zhu HH; Hu J; Zhao WL; Mi JQ; Chen L; Zhu HM; Shen ZX; Jin J; Wang ZY; Li JM; Chen Z; Chen SJ
EBioMedicine; 2015 Jun; 2(6):563-71. PubMed ID: 26285909
[TBL] [Abstract][Full Text] [Related]
45. Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care.
Iland HJ; Wei A; Seymour JF
Best Pract Res Clin Haematol; 2014 Mar; 27(1):39-52. PubMed ID: 24907016
[TBL] [Abstract][Full Text] [Related]
46. Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group.
Callens C; Chevret S; Cayuela JM; Cassinat B; Raffoux E; de Botton S; Thomas X; Guerci A; Fegueux N; Pigneux A; Stoppa AM; Lamy T; Rigal-Huguet F; Vekhoff A; Meyer-Monard S; Ferrand A; Sanz M; Chomienne C; Fenaux P; Dombret H;
Leukemia; 2005 Jul; 19(7):1153-60. PubMed ID: 15889156
[TBL] [Abstract][Full Text] [Related]
47. Early Detection of t(8;21) Chromosomal Translocations During Treatment of PML-RARA Positive Acute Promyelocytic Leukemia: A Case Study.
Neto WK; Serpa M; Sanabani SS; Bueno PT; Velloso ED; Dorlhiac-Llacer PE; Bendit I
Clin Med Insights Oncol; 2010 Dec; 4():163-70. PubMed ID: 21234297
[TBL] [Abstract][Full Text] [Related]
48. A case report of complete remission of acute myeloid leukemia combined with
Ji L; Yang W; Xu XF; Xu YQ
Front Med (Lausanne); 2023; 10():1180757. PubMed ID: 37384044
[TBL] [Abstract][Full Text] [Related]
49. Combined effect of (-)-epigallocatechin-3-gallate and all-trans retinoic acid in
Ly BTK; Chi HT
Biomed Rep; 2020 Oct; 13(4):25. PubMed ID: 32765864
[TBL] [Abstract][Full Text] [Related]
50. Sequential Targeted Treatment for a Geriatric Patient with Acute Myeloid Leukemia with Concurrent FLT3-TKD and IDH1 Mutations.
Chiang RS; Friedman DR; McHugh K; Ramalingam S; Vashistha V
Fed Pract; 2021 Jan; 38(1):40-43. PubMed ID: 33574648
[TBL] [Abstract][Full Text] [Related]
51. [Relapse in a patient with acute promyelocytic leukemia complete remission for 18 years: a case report].
Sun N; Gao L; Yuan Z
Zhonghua Xue Ye Xue Za Zhi; 2018 Apr; 39(4):291. PubMed ID: 29779323
[No Abstract] [Full Text] [Related]
52. Acute promyelocytic leukemia with normal karyotype initially diagnosed on bone marrow touch imprints.
Park J
Blood Res; 2015 Sep; 50(3):130. PubMed ID: 26457278
[No Abstract] [Full Text] [Related]
53. [Acute meningeal cryptoleukemia].
CROIZAT P; DUCLOS
Lyon Med; 1947 Dec; 178(49):817-9. PubMed ID: 18912991
[No Abstract] [Full Text] [Related]
54. Integrating microRNA and mRNA expression profiles of acute promyelocytic leukemia cells to explore the occurrence mechanisms of differentiation syndrome.
Zhang Y; Hou J; Ge F; Cao F; Li H; Wang P; Xu M; Song P; Li X; Wang S; Li J; Han X; Zhao Y; Su Y; Li Y; Fan S; Li L; Zhou J
Oncotarget; 2016 Nov; 7(45):73509-73524. PubMed ID: 27634874
[TBL] [Abstract][Full Text] [Related]
55. Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia.
Baljevic M; Dumitriu B; Lee JW; Paietta EM; Wiernik PH; Racevskis J; Chen C; Stein EM; Gallagher RE; Rowe JM; Appelbaum FR; Powell BL; Larson RA; Coutré SE; Lancet J; Litzow MR; Luger SM; Young NS; Tallman MS
Acta Haematol; 2016; 136(4):210-218. PubMed ID: 27632567
[TBL] [Abstract][Full Text] [Related]
56. Induction treatments for acute promyelocytic leukemia: a network meta-analysis.
Huang J; Sun M; Wang Z; Zhang Q; Lou J; Cai Y; Chen W; Du X
Oncotarget; 2016 Nov; 7(44):71974-71986. PubMed ID: 27713127
[TBL] [Abstract][Full Text] [Related]
57. Arsenic Trioxide and Tretinoin (AsO/ATRA) for Acute Promyelocytic Leukemia (APL).
Damery E; Solimando DA; Waddell JA
Hosp Pharm; 2016 Sep; 51(8):628-632. PubMed ID: 27698500
[TBL] [Abstract][Full Text] [Related]
58. Off-the-shelf CAR-engineered natural killer cells targeting FLT3 enhance killing of acute myeloid leukemia.
Mansour AG; Teng KY; Li Z; Zhu Z; Chen H; Tian L; Ali A; Zhang J; Lu T; Ma S; Lin CM; Caligiuri MA; Yu J
Blood Adv; 2023 Oct; 7(20):6225-6239. PubMed ID: 37379267
[TBL] [Abstract][Full Text] [Related]
59. Evolution of a FLT3-TKD mutated subclone at meningeal relapse in acute promyelocytic leukemia.
Bochtler T; Fröhling S; Weichert W; Endris V; Thiede C; Hutter B; Hundemer M; Ho AD; Krämer A
Cold Spring Harb Mol Case Stud; 2016 Sep; 2(5):a001123. PubMed ID: 27626069
[TBL] [Abstract][Full Text] [Related]
60. [Prevalence and clinical significance of FLT3 mutations in acute promyelocytic leukemia].
Xue MX; Qiu HY; Feng YF; Zhu ZL; Chang WR; Liang JY; Chen SN; Cen JN; Xue YQ; Liu YJ; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):757-61. PubMed ID: 19176014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
